wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37427140-F4A7E722-EE2A-4FC1-84CA-EF6364BF5339
Q37427140-F4A7E722-EE2A-4FC1-84CA-EF6364BF5339
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37427140-F4A7E722-EE2A-4FC1-84CA-EF6364BF5339
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.
P2860
Q37427140-F4A7E722-EE2A-4FC1-84CA-EF6364BF5339
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37427140-F4A7E722-EE2A-4FC1-84CA-EF6364BF5339
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6d4a8f905d21b1e7b25b6e314a09f0982f02c66
P2860
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.